Recurrent and Refractory Diffuse Large B-cell Lymphoma
1 clinical trials · Condition
◉ Watch Recurrent and Refractory Diffuse Large B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma (NCT07011056) | Chengdu Zenitar Biomedical Technology Co., Ltd | 2025-07-18 |
Track Recurrent and Refractory Diffuse Large B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.